Which companies overlap with Grupo Argentino de Tratamiento de la Leucemia Aguda's portfolio?

Top competitors by shared drug class: Abbott, Ascentage Pharma Group Inc., Centre Hospitalier Universitaire de Nice, Janssen Research & Development, LLC, Jiangsu HengRui Medicine Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/grupo-argentino-de-tratamiento-de-la-leucemia-aguda.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Grupo Argentino de Tratamiento de la Leucemia Aguda — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Grupo Argentino de Tratamiento de la Leucemia Aguda pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ARM B: Blocks Therapy Drug	ARM B: Blocks Therapy Drug	phase 3	Beta-blocker	Beta-adrenergic receptor	Oncology
ARM A: Active Comparator Drug	ARM A: Active Comparator Drug	phase 3	BCL-2 inhibitor	BCL-2	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abbott · 1 shared drug class
Ascentage Pharma Group Inc. · 1 shared drug class
Centre Hospitalier Universitaire de Nice · 1 shared drug class
Janssen Research & Development, LLC · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
NHS Greater Glasgow and Clyde · 1 shared drug class
Nanfang Hospital, Southern Medical University · 1 shared drug class
PrECOG, LLC. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Grupo Argentino de Tratamiento de la Leucemia Aguda:

Cite this brief

Drug Landscape (2026). Grupo Argentino de Tratamiento de la Leucemia Aguda — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/grupo-argentino-de-tratamiento-de-la-leucemia-aguda. Accessed 2026-05-18.